Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1979 4
1980 3
1981 2
1983 1
1984 3
1985 1
1986 7
1988 3
1989 3
1990 3
1991 5
1992 4
1993 6
1994 1
1995 6
1996 3
1998 4
1999 6
2000 6
2001 6
2002 10
2003 12
2004 6
2005 10
2006 9
2007 10
2008 8
2009 13
2010 15
2011 21
2012 22
2013 20
2014 29
2015 17
2016 22
2017 22
2018 27
2019 24
2020 27
2021 27
2022 14
2023 20
2024 17
2025 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

457 results

Results by year

Filters applied: . Clear all
Page 1
An overview of meningiomas.
Buerki RA, Horbinski CM, Kruser T, Horowitz PM, James CD, Lukas RV. Buerki RA, et al. Among authors: lukas rv. Future Oncol. 2018 Sep;14(21):2161-2177. doi: 10.2217/fon-2018-0006. Epub 2018 Aug 7. Future Oncol. 2018. PMID: 30084265 Free PMC article. Review.
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma.
Zhao J, Chen AX, Gartrell RD, Silverman AM, Aparicio L, Chu T, Bordbar D, Shan D, Samanamud J, Mahajan A, Filip I, Orenbuch R, Goetz M, Yamaguchi JT, Cloney M, Horbinski C, Lukas RV, Raizer J, Rae AI, Yuan J, Canoll P, Bruce JN, Saenger YM, Sims P, Iwamoto FM, Sonabend AM, Rabadan R. Zhao J, et al. Among authors: lukas rv. Nat Med. 2019 Mar;25(3):462-469. doi: 10.1038/s41591-019-0349-y. Epub 2019 Feb 11. Nat Med. 2019. PMID: 30742119 Free PMC article.
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial.
Fares J, Ahmed AU, Ulasov IV, Sonabend AM, Miska J, Lee-Chang C, Balyasnikova IV, Chandler JP, Portnow J, Tate MC, Kumthekar P, Lukas RV, Grimm SA, Adams AK, Hébert CD, Strong TV, Amidei C, Arrieta VA, Zannikou M, Horbinski C, Zhang H, Burdett KB, Curiel DT, Sachdev S, Aboody KS, Stupp R, Lesniak MS. Fares J, et al. Among authors: lukas rv. Lancet Oncol. 2021 Aug;22(8):1103-1114. doi: 10.1016/S1470-2045(21)00245-X. Epub 2021 Jun 29. Lancet Oncol. 2021. PMID: 34214495 Free PMC article. Clinical Trial.
Paraneoplastic epilepsy.
Serafini A, Lukas RV, VanHaerents S, Warnke P, Tao JX, Rose S, Wu S. Serafini A, et al. Among authors: lukas rv. Epilepsy Behav. 2016 Aug;61:51-58. doi: 10.1016/j.yebeh.2016.04.046. Epub 2016 Jun 12. Epilepsy Behav. 2016. PMID: 27304613 Review.
A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics.
Kumthekar PU, Avram MJ, Lassman AB, Lin NU, Lee E, Grimm SA, Schwartz M, Bell Burdett KL, Lukas RV, Dixit K, Perron I, Zhang H, Gradishar WJ, Pentsova EI, Jeyapalan S, Groves MD, Melisko M, Raizer JJ. Kumthekar PU, et al. Among authors: lukas rv. Neuro Oncol. 2023 Mar 14;25(3):557-565. doi: 10.1093/neuonc/noac195. Neuro Oncol. 2023. PMID: 35948282 Free PMC article. Clinical Trial.
STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma.
Najem H, Lea ST, Tripathi S, Hurley L, Chen CH, William I, Sooreshjani M, Bowie M, Hartley G, Dussold C, Pacheco S, Dmello C, Lee-Chang C, McCortney K, Steffens A, Walshon J, Ott M, Wei J, Marisetty A, Balyasnikova I, Stupp R, Lukas RV, Hu J, James CD, Horbinski CM, Lesniak MS, Ashley DM, Priebe W, Platanias LC, Curran MA, Heimberger AB. Najem H, et al. Among authors: lukas rv. J Clin Invest. 2024 Jun 17;134(12):e175033. doi: 10.1172/JCI175033. J Clin Invest. 2024. PMID: 38941297 Free PMC article.
Nonmalignant Brain Tumors.
Lukas RV, Mrugala MM. Lukas RV, et al. Continuum (Minneap Minn). 2020 Dec;26(6):1495-1522. doi: 10.1212/CON.0000000000000942. Continuum (Minneap Minn). 2020. PMID: 33273170 Review.
ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma.
Arrieta VA, Chen AX, Kane JR, Kang SJ, Kassab C, Dmello C, Zhao J, Burdett KB, Upadhyayula PS, Lee-Chang C, Shilati J, Jaishankar D, Chen L, Gould A, Zhang D, Yuan J, Zhao W, Ling X, Burks JK, Laffleur B, Amidei C, Bruce JN, Lukas RV, Yamaguchi JT, Cieremans D, Rothschild G, Basu U, McCord M, Brat DJ, Zhang H, Cooper LAD, Zhang B, Sims P, Cloughesy TF, Prins R, Canoll P, Stupp R, Heimberger AB, Horbinski C, Iwamoto FM, Rabadan R, Sonabend AM. Arrieta VA, et al. Among authors: lukas rv. Nat Cancer. 2021 Dec;2(12):1372-1386. doi: 10.1038/s43018-021-00260-2. Epub 2021 Nov 29. Nat Cancer. 2021. PMID: 35121903 Free PMC article.
Pediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF fusion pilocytic astrocytoma.
Tripathi S, Najem H, Dussold C, Pacheco S, Du R, Sooreshjani M, Hurley L, Chandler JP, Stupp R, Sonabend AM, Horbinski CM, Lukas RV, Xiu J, Lopez G, Nicolaides TP, Brown V, Wadhwani NR, Lam SK, James CD, Rao G, Castro MG, Heimberger AB, DeCuypere M. Tripathi S, et al. Among authors: lukas rv. J Clin Invest. 2024 Aug 13;134(19):e177413. doi: 10.1172/JCI177413. J Clin Invest. 2024. PMID: 39137048 Free PMC article.
Immunotherapy in Glioblastoma.
Williams A, Lukas RV. Williams A, et al. Among authors: lukas rv. Cancer Treat Res. 2025;129:103-118. doi: 10.1007/978-3-031-97242-3_6. Cancer Treat Res. 2025. PMID: 40847231 Review.
457 results